Article scientifique - questionsmedicales.fr

Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591

doi: 10.1161/CIRCRESAHA.118.313591 pubmed: 30653442 pmcid: 6342482

Nidorf SM, Fiolet ATL, Mosterd A et al (2020) Colchicine in patients with chronic coronary disease. N Engl J Med 383:1838–1847. https://doi.org/10.1056/NEJMoa2021372

doi: 10.1056/NEJMoa2021372 pubmed: 32865380

Tardif J-C, Kouz S, Waters DD et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381:2497–2505. https://doi.org/10.1056/NEJMoa1912388

doi: 10.1056/NEJMoa1912388 pubmed: 31733140

Ridker PM, Everett BM, Pradhan A et al (2019) Low-dose methotrexate for the Prevention of atherosclerotic events. N Engl J Med 380:752–762. https://doi.org/10.1056/NEJMoa1809798

doi: 10.1056/NEJMoa1809798 pubmed: 30415610

Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377:1119–1131. https://doi.org/10.1056/NEJMoa1707914

doi: 10.1056/NEJMoa1707914 pubmed: 28845751

Rossi-Semerano L, Fautrel B, Wendling D et al (2015) Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey. Orphanet J Rare Dis 10:19. https://doi.org/10.1186/s13023-015-0228-7

doi: 10.1186/s13023-015-0228-7 pubmed: 25758134 pmcid: 4340831

Khan N, Abbas AM, Whang N et al (2012) Incidence of Liver Toxicity in Inflammatory Bowel Disease patients treated with methotrexate: a Meta-analysis of clinical trials. Inflamm Bowel Dis 18:359–367. https://doi.org/10.1002/ibd.21820

doi: 10.1002/ibd.21820 pubmed: 21751301

Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468–471. https://doi.org/10.1126/science.1411543

doi: 10.1126/science.1411543 pubmed: 1411543

Nakashima Y, Plump AS, Raines EW et al (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133–140. https://doi.org/10.1161/01.atv.14.1.133

doi: 10.1161/01.atv.14.1.133 pubmed: 8274468

Hag AMF, Pedersen SF, Christoffersen C et al (2012) 18F-FDG PET imaging of Murine Atherosclerosis: Association with Gene expression of key molecular markers. PLoS ONE 7:e50908. https://doi.org/10.1371/journal.pone.0050908

doi: 10.1371/journal.pone.0050908 pubmed: 23226424 pmcid: 3511408

Ahmed M, Tegnebratt T, Tran TA et al (2020) Molecular Imaging of Inflammation in a mouse model of atherosclerosis using a zirconium-89-Labeled probe. Int J Nanomed Volume 15:6137–6152. https://doi.org/10.2147/IJN.S256395

doi: 10.2147/IJN.S256395

Zhao Y, Kuge Y, Zhao S et al (2008) Prolonged High-Fat Feeding enhances aortic

doi: 10.2967/jnumed.108.051847 pubmed: 18794270

Rucher G, Cameliere L, Fendri J et al (2019) Molecular imaging of endothelial activation and mineralization in a mouse model of accelerated atherosclerosis. EJNMMI Res 9:80. https://doi.org/10.1186/s13550-019-0550-5

doi: 10.1186/s13550-019-0550-5 pubmed: 31440854 pmcid: 6706501

Laurberg JM, Olsen AK, Hansen SB et al (2007) Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis 192:275–282. https://doi.org/10.1016/j.atherosclerosis.2006.07.019

doi: 10.1016/j.atherosclerosis.2006.07.019 pubmed: 16919635

Plump AS, Smith JD, Hayek T et al (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343–353. https://doi.org/10.1016/0092-8674(92)90362-g

doi: 10.1016/0092-8674(92)90362-g pubmed: 1423598

Winkels H, Ehinger E, Vassallo M et al (2018) Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis defined by single-cell RNA-Sequencing and Mass Cytometry. Circ Res 122:1675–1688. https://doi.org/10.1161/CIRCRESAHA.117.312513

doi: 10.1161/CIRCRESAHA.117.312513 pubmed: 29545366 pmcid: 5993603

Bro S, Bentzon JF, Falk E et al (2003) Chronic renal failure accelerates atherogenesis in apolipoprotein E–Deficient mice. J Am Soc Nephrol 14:2466–2474. https://doi.org/10.1097/01.ASN.0000088024.72216.2E

doi: 10.1097/01.ASN.0000088024.72216.2E pubmed: 14514724

Ivanovski O, Nikolov IG, Davceva O et al (2015) Compared with radical nephrectomy, Nephron-sparing partial nephrectomy protects apolipoprotein E–deficient mice from atherosclerosis progression. Urology 85. https://doi.org/10.1016/j.urology.2015.02.004 .:1215.e9-1215.e15

Bro S, Moeller F, Andersen CB et al (2004) Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 15:1495–1503. https://doi.org/10.1097/01.asn.0000128371.33195.7b

doi: 10.1097/01.asn.0000128371.33195.7b pubmed: 15153560

Thackeray JT, Bankstahl JP, Wang Y et al (2015) Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice. Eur J Nucl Med Mol Imaging 42:771–780. https://doi.org/10.1007/s00259-014-2956-7

doi: 10.1007/s00259-014-2956-7 pubmed: 25389013

Cussó L, Musteanu M, Mulero F et al (2019) Effects of a ketogenic Diet on [18F]FDG-PET imaging in a mouse model of Lung Cancer. Mol Imaging Biol 21:279–285. https://doi.org/10.1007/s11307-018-1233-8

doi: 10.1007/s11307-018-1233-8 pubmed: 29968182

Kim C, Kim IH, Kim S et al (2011) Comparison of the intraperitoneal, Retroorbital and per oral routes for F-18 FDG Administration as Effective Alternatives to Intravenous Administration in Mouse Tumor models using small animal PET/CT studies. Nucl Med Mol Imaging 45:169–176. https://doi.org/10.1007/s13139-011-0087-7

doi: 10.1007/s13139-011-0087-7 pubmed: 24900000 pmcid: 4043002

Kikinis R, Pieper SD, Vosburgh KG (2014) 3D slicer: a platform for subject-specific image analysis, visualization, and clinical support. In: Jolesz FA (ed) Intraoperative Imaging and image-guided therapy. Springer New York, New York, NY, pp 277–289

doi: 10.1007/978-1-4614-7657-3_19

Kapur T, Pieper S, Fedorov A et al (2016) Increasing the impact of medical image computing using community-based open-access hackathons: the NA-MIC and 3D slicer experience. Med Image Anal 33:176–180. https://doi.org/10.1016/j.media.2016.06.035

doi: 10.1016/j.media.2016.06.035 pubmed: 27498015 pmcid: 5003088

Fedorov A, Beichel R, Kalpathy-Cramer J et al (2012) 3D slicer as an image computing platform for the quantitative Imaging Network. Magn Reson Imaging 30:1323–1341. https://doi.org/10.1016/j.mri.2012.05.001

doi: 10.1016/j.mri.2012.05.001 pubmed: 22770690 pmcid: 3466397

Fedorov A, Clunie D, Ulrich E et al (2016) DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer research. PeerJ 4:e2057. https://doi.org/10.7717/peerj.2057

doi: 10.7717/peerj.2057 pubmed: 27257542 pmcid: 4888317

Cilla M, Pérez MM, Peña E, Martínez MA (2016) Effect of Diet and Age on arterial stiffening due to atherosclerosis in ApoE–/– mice. Ann Biomed Eng 44:2202–2217. https://doi.org/10.1007/s10439-015-1486-1

doi: 10.1007/s10439-015-1486-1 pubmed: 26502169

Bankhead P, Loughrey MB, Fernández JA et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878. https://doi.org/10.1038/s41598-017-17204-5

doi: 10.1038/s41598-017-17204-5 pubmed: 29203879 pmcid: 5715110

Liu J, Kerwin WS, Caldwell JH et al (2016) High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake. Int J Cardiovasc Imaging 32:145–152. https://doi.org/10.1007/s10554-015-0739-2

doi: 10.1007/s10554-015-0739-2 pubmed: 26280889

Massy ZA, Ivanovski O, Nguyen-Khoa T et al (2005) Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16:109–116. https://doi.org/10.1681/ASN.2004060495

doi: 10.1681/ASN.2004060495 pubmed: 15563564

Blomberg BA, Thomassen A, Takx RAP et al (2014) Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. J Nucl Cardiol 21:588–597. https://doi.org/10.1007/s12350-014-9884-6

doi: 10.1007/s12350-014-9884-6 pubmed: 24633502

Wenning C, Kloth C, Kuhlmann MT et al (2014) Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis. Atherosclerosis 234:276–282. https://doi.org/10.1016/j.atherosclerosis.2014.03.008

doi: 10.1016/j.atherosclerosis.2014.03.008 pubmed: 24704630

Fazio S, Babaev VR, Murray AB et al (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647–4652. https://doi.org/10.1073/pnas.94.9.4647

doi: 10.1073/pnas.94.9.4647 pubmed: 9114045 pmcid: 20778

Wu H, Gower RM, Wang H et al (2009) Functional role of CD11c

doi: 10.1161/CIRCULATIONAHA.108.823740 pubmed: 19433759 pmcid: 2716173

Gutiérrez-Muñoz C, Méndez‐Barbero N, Svendsen P et al (2020) CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice. FASEB J 34:14960–14976. https://doi.org/10.1096/fj.202000177R

doi: 10.1096/fj.202000177R pubmed: 32924185

McLaren JE, Ramji DP (2009) Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 20:125–135. https://doi.org/10.1016/j.cytogfr.2008.11.003

doi: 10.1016/j.cytogfr.2008.11.003 pubmed: 19041276

Tyrrell DJ, Goldstein DR (2021) Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol 18:58–68. https://doi.org/10.1038/s41569-020-0431-7

doi: 10.1038/s41569-020-0431-7 pubmed: 32918047

Kamari Y, Shaish A, Shemesh S et al (2011) Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α. Biochem Biophys Res Commun 405:197–203. https://doi.org/10.1016/j.bbrc.2011.01.008

doi: 10.1016/j.bbrc.2011.01.008 pubmed: 21219852

Harry BL, Sanders JM, Feaver RE et al (2008) Endothelial cell PECAM-1 promotes atherosclerotic lesions in Areas of Disturbed Flow in ApoE-Deficient mice. Arterioscler Thromb Vasc Biol 28:2003–2008. https://doi.org/10.1161/ATVBAHA.108.164707

doi: 10.1161/ATVBAHA.108.164707 pubmed: 18688018 pmcid: 2651147

Zibara K, Chignier E, Covacho C et al (2000) Modulation of expression of endothelial intercellular adhesion Molecule-1, platelet–endothelial cell adhesion Molecule-1, and vascular cell adhesion Molecule-1 in aortic Arch lesions of apolipoprotein E–Deficient compared with wild-type mice. Arterioscler Thromb Vasc Biol 20:2288–2296. https://doi.org/10.1161/01.ATV.20.10.2288

doi: 10.1161/01.ATV.20.10.2288 pubmed: 11031217

Rival Y, Del Maschio A, Rabiet MJ et al (1996) Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 157:1233–1241

doi: 10.4049/jimmunol.157.3.1233 pubmed: 8757631

Stewart RJ, Kashour TS, Marsden PA (1996) Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 156:1221–1228

doi: 10.4049/jimmunol.156.3.1221 pubmed: 8558001

Gisterå A, Hansson GK (2017) The immunology of atherosclerosis. Nat Rev Nephrol 13:368–380. https://doi.org/10.1038/nrneph.2017.51

doi: 10.1038/nrneph.2017.51 pubmed: 28392564

Buzello M, Törnig J, Faulhaber J et al (2003) The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in Uremia. J Am Soc Nephrol 14:311–316. https://doi.org/10.1097/01.ASN.0000045048.71975.FC

doi: 10.1097/01.ASN.0000045048.71975.FC pubmed: 12538731

Ge S, Hertel B, Koltsova EK et al (2013) Increased atherosclerotic lesion formation and vascular leukocyte Accumulation in Renal Impairment are mediated by Interleukin-17A. Circ Res 113:965–974. https://doi.org/10.1161/CIRCRESAHA.113.301934

doi: 10.1161/CIRCRESAHA.113.301934 pubmed: 23908345

Jing YJ, Ni JW, Ding FH et al (2016) p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE–/– mice. Kidney Int 89:439–449. https://doi.org/10.1038/ki.2015.287

doi: 10.1038/ki.2015.287 pubmed: 26466319

Phan O, Ivanovski O, Nguyen-Khoa T et al (2005) Sevelamer prevents Uremia-enhanced atherosclerosis progression in apolipoprotein E–Deficient mice. Circulation 112:2875–2882. https://doi.org/10.1161/CIRCULATIONAHA105.541854

doi: 10.1161/CIRCULATIONAHA105.541854 pubmed: 16267260

Jonsson AL, Bäckhed F (2017) Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 14:79–87. https://doi.org/10.1038/nrcardio.2016.183

doi: 10.1038/nrcardio.2016.183 pubmed: 27905479

Robertson SJ, Lemire P, Maughan H et al (2019) Comparison of co-housing and littermate methods for Microbiota standardization in mouse models. Cell Rep 27:1910–1919e2. https://doi.org/10.1016/j.celrep.2019.04.023

doi: 10.1016/j.celrep.2019.04.023 pubmed: 31067473

Caligiuri G, Nicoletti A, Zhou X et al (1999) Effects of sex and age on atherosclerosis and autoimmunity in apoe-deficient mice. Atherosclerosis 145:301–308. https://doi.org/10.1016/s0021-9150(99)00081-7

doi: 10.1016/s0021-9150(99)00081-7 pubmed: 10488957

Meester EJ, Krenning BJ, de Swart J et al (2019) Perspectives on small animal Radionuclide Imaging; considerations and advances in atherosclerosis. Front Med (Lausanne) 6:39. https://doi.org/10.3389/fmed.2019.00039

doi: 10.3389/fmed.2019.00039 pubmed: 30915335

McKenney-Drake ML, Moghbel MC, Paydary K et al (2018) 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 45:2190–2200. https://doi.org/10.1007/s00259-018-4078-0

doi: 10.1007/s00259-018-4078-0 pubmed: 29978245 pmcid: 6182398

Phan O, Ivanovski O, Nikolov IG et al (2008) Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrol Dial Transpl 23:82–90. https://doi.org/10.1093/ndt/gfm699

doi: 10.1093/ndt/gfm699

Ivanovski O, Szumilak D, Nguyen-Khoa T et al (2005) The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 67:2288–2294. https://doi.org/10.1111/j.1523-1755.2005.00332.x

doi: 10.1111/j.1523-1755.2005.00332.x pubmed: 15882270

Bro S, Borup R, Andersen CB et al (2006) Uremia-Specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E–Deficient mice. Arterioscler Thromb Vasc Biol 26:570–575. https://doi.org/10.1161/01.ATV.0000201060.47945.cb

doi: 10.1161/01.ATV.0000201060.47945.cb pubmed: 16373611

Belmokhtar K, Ortillon J, Jaisson S et al (2019) Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression. Nephrol Dial Transpl 34:2018–2030. https://doi.org/10.1093/ndt/gfz012

doi: 10.1093/ndt/gfz012

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Samuel Deshayes (S)

Pauline Ruello (P)

Christophe Simard (C)

Pierre-Antoine Dupont (PA)

Caroline Bauge (C)

Ahmed Abbas (A)

Hubert de Boysson (H)

Achille Aouba (A)

Alain Manrique (A)

Classifications MeSH